Range
39.18 - 40.66
Vol / Avg.
89.1K/198.8K
Div / Yield
-
52 Wk
27.15 - 76.63
Mkt Cap
1.4B
Payout Ratio
-
Open
39.18
P/E
-
EPS
-0.66
Shares
33.7M
Outstanding
33.7M
Total Float
25.1M
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-20
REV
Q1 2021Est.ActualSurprise
EPS-0.560
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BCABBioAtla0%1.4B

BioAtla Frequently Asked Questions

Q

How do I buy BioAtla (BCAB) stock?

A

You can purchase shares of BioAtla (NASDAQ: BCAB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BioAtla's (BCAB) competitors?

A

There are no as such competitors for BioAtla.

Q

What is the target price for BioAtla (BCAB) stock?

A

The latest price target for BioAtla (NASDAQ: BCAB) was reported by Roth Capital on June 28, 2021. The analyst firm set a price target for 75.00 expecting BCAB to rise to within 12 months (a possible 85.83% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for BioAtla (BCAB)?

A

The stock price for BioAtla (NASDAQ: BCAB) is $40.36 last updated Today at 8:00:02 PM.

Q

Does BioAtla (BCAB) pay a dividend?

A

There are no upcoming dividends for BioAtla.

Q

When is BioAtla (NASDAQ:BCAB) reporting earnings?

A
BioAtla’s Q2 earnings are confirmed for after-market on August 20, 2021.
Q

Is BioAtla (BCAB) going to split?

A

There is no upcoming split for BioAtla.

Q

What sector and industry does BioAtla (BCAB) operate in?

A

BioAtla is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.